Metabolize
Dover, United States · Founded 2024
- Headquarters
- Dover, Delaware
- Founded
- 2024
- Business Model
- B2C
- Website
- metabolize.life
- Last Round
- SeedAug 2025
- Rounds
- 1
About
Metabolize is a Stanford-originated startup pioneering a new category of human nutrition called precision metabolites — biological signals designed to support sustainable weight and metabolic health without GLP-1 drugs. Backed by IndieBio's SF accelerator, the company is building a science-backed, non-GLP-1 platform to help people maintain healthy weight and metabolic function after GLP-1 therapy, for everyone, everywhere.
Summary
Metabolize is a Biotech company based in Dover, United States, founded in 2024. Its most recent funding was a Seed round in Aug 2025. Investors include SOSV.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...